COATS LONNEL Insider Trading Activity

Average Profitability
6.36%
Insider Buys Quantity
12
Insider Buys Sum
$1.95M
Insider Sells Quantity
3
Insider Sells Sum
$3.52M

Insider Activity of COATS LONNEL

Biography of COATS LONNEL

No biography is available at this moment.

2023-11-16PurchaseLexicon Pharmaceuticals, Inc.
LXRX
Chief Executive Officer
90,000
0.0365%
$1.05$94,797+60.85%
2023-11-10PurchaseLexicon Pharmaceuticals, Inc.
LXRX
Chief Executive Officer
10,000
0.0041%
$1.01$10,100+69.31%
2023-06-29PurchaseLexicon Pharmaceuticals, Inc.
LXRX
Chief Executive Officer
10,000
0.0053%
$2.16$21,600-21.66%
2023-06-26PurchaseLexicon Pharmaceuticals, Inc.
LXRX
Chief Executive Officer
10,000
0.0053%
$2.18$21,792-21.43%
2023-06-23PurchaseLexicon Pharmaceuticals, Inc.
LXRX
Chief Executive Officer
10,000
0.0056%
$2.50$24,950-27.64%
2023-06-22PurchaseLexicon Pharmaceuticals, Inc.
LXRX
Chief Executive Officer
40,000
0.0211%
$2.31$92,400-25.86%
2019-09-18PurchaseLexicon Pharmaceuticals, Inc.
LXRX
President and CEO
100,000
0.0768%
$3.10$310,000-42.37%
2019-09-17PurchaseLexicon Pharmaceuticals, Inc.
LXRX
President and CEO
100,000
0.1001%
$3.13$312,806-24.83%
2019-08-19PurchaseLexicon Pharmaceuticals, Inc.
LXRX
President and CEO
6,000
0.0056%
$1.40$8,388+60.99%
2019-08-16PurchaseLexicon Pharmaceuticals, Inc.
LXRX
President and CEO
74,000
0.0685%
$1.35$99,669+67.88%
2017-11-15PurchaseLexicon Pharmaceuticals, Inc.
LXRX
President and CEO
20,000
0.0185%
$9.91$198,200-1.67%
2017-09-15PurchaseLexicon Pharmaceuticals, Inc.
LXRX
President and CEO
60,000
0.0576%
$12.55$752,866-17.22%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.